Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: BOD PAY, DEFENDING YOUR INVESTMENT, AND CONCERNS

What to believe?

During the nine months ended February 28, 2010, TPL entered into licensing agreements with third parties, pursuant to which PDS recorded aggregate proceeds of $12,898,655.

vs

Approx $260,00 equals 85% of revenues.

.

While our current liquid cash resources as of February 28, 2010, are expected to provide the funds necessary to support our operations through at least the next twelve months

vs

current conditions for Working Capital at PTSC could necessitate the sale of stock of either our Preferred Shares or from the 200,000,000 Common Shares still unissued. At todays price, the potential float could increase by 50% and YOUR "share equilivent representation" in this company could be cut by up to 1/3, for a mere $24M.

Where's "Uncle Charlie"?

.

.

.

Be well

Share
New Message
Please login to post a reply